← Back to All Filings

H.B. Fuller CFO Awarded Phantom Units Valued at $9.4k

Low SignificanceOctober 14, 2025 at 10:06:07 AM EDT

FULLER H B CO

$FUL4CIK: 0000039368

Subscribe to track FUL

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

H.B. Fuller CFO Awarded Phantom Units Valued at $9.4k

Company: FULLER H B CO (FUL) Form: 4 | Filed: 2025-10-14 Significance: Low

Insider: Corkrean John J Title: Executive VP and CFO | Relationship: Officer

Transaction: • Type: Grant • Shares: 165.1 Phantom Units • Price: $57.09 • Value: $9,425.56 • Owned After: 26,936.83

Key Insight: This is a routine grant of phantom units as part of executive compensation, not an open-market purchase. It has low significance as a trading signal.

Market Context: The transaction is coded 'A' for Award, indicating it's part of a pre-established compensation plan rather than a discretionary investment by the CFO.

View Full Filing

This is PUBLIC SEC data for educational purposes. Not investment advice.

Comprehensive Analysis

SEC Filing Analysis: FULLER H B CO (FUL)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: The Executive VP and CFO, John J. Corkrean, was awarded 165.1 phantom units, valued at approximately $9,426, as part of a compensation plan. This is not an open-market transaction and carries minimal weight as a predictive market signal.
  • Market Impact: Neutral. As a routine compensation-related grant, this type of transaction is not expected to influence the stock price or trading volume.

Company Information

FieldValue
CompanyFULLER H B CO
Ticker SymbolFUL
CIK0000039368
IndustryAdhesives & Sealants

Insider Information

FieldValue
NameCorkrean John J
CIK0001431849
Title/PositionExecutive VP and CFO
RelationshipOfficer

Transaction Details

FieldValue
Form Type4
Transaction Date2025-10-10
Transaction CodeA (Award)
Security TypePhantom Units
Shares Involved165.1
Price Per Share$57.09
Total Value$9,425.56
Shares Owned After26,936.83 (of this security type)
Ownership TypeDirect

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The transaction is an award (Code 'A'), a common form of non-cash executive compensation. It does not represent a discretionary investment decision by the insider based on their outlook for the company. The market typically views such grants as routine and non-indicative of future performance.

Volume & Sentiment

  • Expected Volume Impact: Negligible. Compensation-related grants do not affect trading volume as no shares are traded on the open market.
  • Sentiment Indicator: Neutral. The filing does not provide any new information that would shift market sentiment towards bullish or bearish.

Investment Insights

Positive Market Indicators

  • Aligning executive interests with shareholder interests through equity-based compensation is a standard corporate governance practice.

Risk Factors

  • No immediate risk factors are apparent from this specific transaction.

Key Takeaways

  1. Compensation, Not Investment: The transaction is a grant of phantom units, not a purchase of stock with the insider's own capital.
  2. Low Value: The total value of the transaction ($9.4k) is minor relative to the executive's position and overall holdings.
  3. No Market Signal: This filing should be considered informational and does not provide a bullish or bearish signal for the stock.

Contextual Analysis

Timing Significance

  • The transaction date is part of a routine reporting period. There is no apparent significance to the timing of this grant in relation to broader market events.

Transaction Context

  • The transaction code 'A' explicitly defines this as an award.
  • Footnote 1 clarifies that the phantom units convert into common stock on a 1-for-1 basis.
  • Footnote 2 specifies that conversion occurs upon termination events or at a date selected by the participant, indicating these are part of a deferred compensation plan.

Company Context

  • H.B. Fuller (FUL) operates in the specialty chemicals industry, specifically adhesives and sealants. Analysis of this filing should be paired with a broader look at the company's recent earnings reports, industry trends, and overall financial health.

Risk Assessment

Risk Level: Low

Risk Factors

  • This filing itself presents no notable risks. The primary risk is misinterpreting a routine compensation grant as a meaningful insider purchase.

Market Considerations

  • Investors should focus on fundamental analysis (earnings, revenue, margins) and macroeconomic factors affecting the chemical industry rather than this specific insider filing.
  • The filing does show the insider has significant holdings in other derivative securities like stock options and RSUs, indicating long-term alignment with the company.

IMPORTANT DISCLAIMER: This analysis is for informational purposes only and is not intended as investment advice. The information presented is based on publicly available SEC filings and should not be construed as a recommendation to buy, sell, or hold any securities. Past performance does not guarantee future results. All investments carry risk, including the potential loss of principal. Please consult with a qualified financial advisor before making any investment decisions.

Analysis generated on 2025-10-14 | Data source: SEC EDGAR

Topics:#SECFiling#InsiderTrading#FUL#FULStock#Form4#StockGrant#LowSignificance#StockMarket#Investing#HBFuller

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.